Clinical Trial Detail

NCT ID NCT02580448
Title A Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of VT-464 in Patients With Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Innocrin Pharmaceutical
Indications

triple-receptor negative breast cancer

estrogen-receptor positive breast cancer

Therapies

VT-464

Age Groups: adult

Additional content available in CKB BOOST